on Medios AG (isin : DE000A1MMCC8)
Medios AG: Reallocation of Bencis Shares
Berlin, October 24, 2025 – Medios AG, a leading provider of Specialty Pharma in Europe, announced the reallocation of Bencis Capital Partners B.V.'s entire shareholding in the company. Bencis sold its shares, representing approximately 6.7% of Medios' share capital, to institutional investor Janus Henderson Group Plc. The transaction was facilitated by Berenberg.
Bencis acquired 1,700,000 Medios shares in 2024 during a capital increase linked to Medios' acquisition of Ceban Pharmaceuticals B.V. Matthias Gärtner, CEO of Medios AG, expressed confidence in Janus Henderson as a new, long-term investor, emphasizing the company's strategic growth potential.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Medios AG news